Literature DB >> 22847094

The effects of prehospital plasma on patients with injury: a prehospital plasma resuscitation.

Brian D Kim1, Martin D Zielinski, Donald H Jenkins, Henry J Schiller, Kathleen S Berns, Scott P Zietlow.   

Abstract

BACKGROUND: The prehospital resuscitation of the exsanguinating patient with trauma is time and resource dependent. Rural trauma care magnifies these factors because transportation time to definitive care is increased. To address the early resuscitation needs and trauma-induced coagulopathy in the exsanguinating patient with trauma an aeromedical prehospital thawed plasma-first transfusion protocol was used.
METHODS: Retrospective review of trauma and flight registries between February 1, 2009, and May 31, 2011, was performed. The study population included all patients with traumatic injury transported by rotary wing aircraft who met criteria for massive transfusion protocol
RESULTS: A total of 59 patients identified over 28 months met criteria for initiation of aeromedical initiation of prehospital blood product resuscitation. Nine patients received thawed plasma-first protocol compared with 50 controls. The prehospital plasma group was more commonly on warfarin (22 vs. 2%, p = 0.036) and had a greater degree of coagulopathy measured by international normalized ratio at baseline (2.6 vs. 1.5, p = 0.004) and trauma center arrival (1.6 vs. 1.3, p < 0.001). The prehospital plasma group had a predicted mortality nearly three times greater than controls based on Trauma and Injury Severity Score (0.24 vs. 0.66, p = 0.005). The use of prehospital plasma resuscitation led to a plasma-red blood cell ratio that more closely approximated a 1:1 resuscitation en route (1.3:1.0 vs. not applicable, p < 0.001), at 30 minutes (1.3:1.0 vs. 0.14:1.0, p < 0.001), at 6 hours (0.95:1.0 vs. 0.42:1.0, p < 0.001), and at 24 hours (1.0:1.0 vs. 0.45:1.0, p < 0.001). An equivalent amount of packed red blood cells were transfused between the groups. Despite more significant hypotension, less crystalloid was used in the prehospital thawed plasma group, through 24 hours after injury (6.3 vs. 16.4 L, p = 0.001).
CONCLUSION: Use of plasma-first resuscitation in the helicopter system creates a field ready, mobile blood bank, allowing early resuscitation of the patient demonstrating need for massive transfusion. There was early treatment of trauma-induced coagulopathy. Although there was not a survival benefit demonstrated, there was resultant damage control resuscitation extending to 24 hours in the plasma-first cohort.

Entities:  

Mesh:

Year:  2012        PMID: 22847094     DOI: 10.1097/TA.0b013e31826060ff

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  19 in total

1.  The state of the science of whole blood: lessons learned at Mayo Clinic.

Authors:  James R Stubbs; Martin D Zielinski; Donald Jenkins
Journal:  Transfusion       Date:  2016-04       Impact factor: 3.157

Review 2.  Advances in damage control resuscitation and surgery: implications on the organization of future military field forces.

Authors:  Homer Tien; Andrew Beckett; Naisan Garraway; Max Talbot; Dylan Pannell; Thamer Alabbasi
Journal:  Can J Surg       Date:  2015-06       Impact factor: 2.089

3.  Pre-trauma center red blood cell transfusion is associated with improved early outcomes in air medical trauma patients.

Authors:  Joshua B Brown; Jason L Sperry; Anisleidy Fombona; Timothy R Billiar; Andrew B Peitzman; Francis X Guyette
Journal:  J Am Coll Surg       Date:  2015-01-24       Impact factor: 6.113

4.  Pretrauma center red blood cell transfusion is associated with reduced mortality and coagulopathy in severely injured patients with blunt trauma.

Authors:  Joshua B Brown; Mitchell J Cohen; Joseph P Minei; Ronald V Maier; Michaela A West; Timothy R Billiar; Andrew B Peitzman; Ernest E Moore; Joseph Cuschieri; Jason L Sperry
Journal:  Ann Surg       Date:  2015-05       Impact factor: 12.969

5.  Exploring ethical conflicts in emergency trauma research: the COMBAT (Control of Major Bleeding after Trauma) study experience.

Authors:  Theresa L Chin; Ernest E Moore; Marilyn E Coors; James G Chandler; Arsen Ghasabyan; Jeffrey N Harr; John R Stringham; Christopher R Ramos; Sarah Ammons; Anirban Banerjee; Angela Sauaia
Journal:  Surgery       Date:  2014-10-14       Impact factor: 3.982

6.  Prehospital blood transfusions in pediatric trauma and nontrauma patients: a single-center review of safety and outcomes.

Authors:  Aodhnait S Fahy; Cornelius A Thiels; Stephanie F Polites; Maile Parker; Michael B Ishitani; Christopher R Moir; Kathleen Berns; James R Stubbs; Donald H Jenkins; Scott P Zietlow; Martin D Zielinski
Journal:  Pediatr Surg Int       Date:  2017-05-25       Impact factor: 1.827

7.  Multicenter observational prehospital resuscitation on helicopter study.

Authors:  John B Holcomb; Michael D Swartz; Stacia M DeSantis; Thomas J Greene; Erin E Fox; Deborah M Stein; Eileen M Bulger; Jeffrey D Kerby; Michael Goodman; Martin A Schreiber; Martin D Zielinski; Terence O'Keeffe; Kenji Inaba; Jeffrey S Tomasek; Jeanette M Podbielski; Savitri N Appana; Misung Yi; Charles E Wade
Journal:  J Trauma Acute Care Surg       Date:  2017-07       Impact factor: 3.313

8.  Resuscitate early with plasma and platelets or balance blood products gradually: findings from the PROMMTT study.

Authors:  Deborah J del Junco; John B Holcomb; Erin E Fox; Karen J Brasel; Herb A Phelan; Eileen M Bulger; Martin A Schreiber; Peter Muskat; Louis H Alarcon; Mitchell J Cohen; Bryan A Cotton; Charles E Wade; John G Myers; Mohammad H Rahbar
Journal:  J Trauma Acute Care Surg       Date:  2013-07       Impact factor: 3.313

9.  Modern resuscitation of hemorrhagic shock: what is on the horizon?

Authors:  D T Martin; M A Schreiber
Journal:  Eur J Trauma Emerg Surg       Date:  2014-06-17       Impact factor: 3.693

10.  Prehospital Blood Transfusions in Non-Trauma Patients.

Authors:  Cornelius A Thiels; Johnathon M Aho; Aoidhnait S Fahy; Maile E Parker; Amy E Glasgow; Kathleen S Berns; Elizabeth B Habermann; Scott P Zietlow; Martin D Zielinski
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.